4
Changes in Ownership
CRESCENT BIOPHARMA, INC. Filed Acc 0001209191-20-032302
Options or other derivatives
- Director acquired 21,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Goldberg Mark Alan Director | 2020-05-22 | Grant or award · Stock Option (right to buy) | +21,000 | 21,000 | D | ||
Loading xslF345X03/doc4.xml…